Back to Search
Start Over
CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1.
- Source :
-
The Journal of experimental medicine [J Exp Med] 1998 Jul 20; Vol. 188 (2), pp. 297-304. - Publication Year :
- 1998
-
Abstract
- This report investigates the role of OX40 ligand (OX40L) and its receptor, OX40, expressed on activated B and T cells, respectively, in promoting the differentiation of T helper type 2 (Th2) CD4 T cells. These molecules are expressed in vivo by day 2 after priming with T cell- dependent antigens. Their expression coincides with the appearance of immunoglobulin (Ig)G switch transcripts and mRNA for interleukin (IL)-4 and interferon (IFN)-gamma, suggesting that this molecular interaction plays a role in early cognate interactions between B and T cells. In vitro, we report that costimulation of naive, CD62Lhigh CD4 T cells through OX40 promotes IL-4 expression and upregulates mRNA for the chemokine receptor, blr-1, whose ligand is expressed in B follicles and attracts lymphocytes to this location. Furthermore, T cell stimulation through OX40 inhibits IFN-gamma expression in both CD8 T cells and IL-12-stimulated CD4 T cells. Although this signal initiates IL-4 expression, IL-4 itself is strongly synergistic. Our data suggest that OX40L on antigen-activated B cells instructs naive T cells to differentiate into Th2 cells and migrate into B follicles, where T cell-dependent germinal centers develop.
- Subjects :
- Animals
CD4-Positive T-Lymphocytes cytology
Cell Differentiation immunology
Interleukin-4 biosynthesis
Mice
OX40 Ligand
Receptors, Chemokine biosynthesis
Th1 Cells cytology
Th1 Cells immunology
Th2 Cells cytology
Th2 Cells immunology
Tumor Necrosis Factors
B-Lymphocytes immunology
CD4-Positive T-Lymphocytes immunology
Interleukin-4 immunology
Lymphocyte Activation
Lymphocyte Cooperation immunology
Membrane Glycoproteins
Receptors, Chemokine immunology
Receptors, Tumor Necrosis Factor immunology
Subjects
Details
- Language :
- English
- ISSN :
- 0022-1007
- Volume :
- 188
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- The Journal of experimental medicine
- Publication Type :
- Academic Journal
- Accession number :
- 9670042
- Full Text :
- https://doi.org/10.1084/jem.188.2.297